Peter M Rothwell Selected Research

Inflammation (Inflammations)

4/2024	Plasma fibrinogen and risk of vascular recurrence after ischaemic stroke: An individual participant and summary-level data meta-analysis of 11 prospective studies.
1/2023	C-Reactive Protein, Interleukin-6, and Vascular Recurrence After Stroke: An Individual Participant Data Meta-Analysis.
1/2021	Associations of blood biomarkers with glomerular filtration rate in patients with TIA and stroke: population-based study.
11/2016	Brain Atrophy, N-Terminal Brain Natriuretic Peptide, and Carotid Disease: Interconnecting Relationships Between Cerebral Perfusion, Cardiovascular Disease, Inflammation, and Cognitive Decline.
10/2014	Population-based study of blood biomarkers in prediction of subacute recurrent stroke.
9/2013	Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease.
3/2013	Histological features of carotid plaque in patients with ocular ischemia versus cerebral events.
10/2010	Histological features of symptomatic carotid plaques in relation to age and smoking: the oxford plaque study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter M Rothwell Research Topics

Disease

140	Stroke (Strokes) 05/2024 - 01/2003
65	Ischemic Stroke 04/2024 - 10/2004
29	Transient Ischemic Attack 01/2024 - 10/2004
26	Carotid Stenosis (Carotid Artery Stenosis) 12/2022 - 07/2003
18	Pathologic Constriction (Stenosis) 12/2022 - 01/2004
14	Hypertension (High Blood Pressure) 11/2023 - 04/2005
14	Neoplasms (Cancer) 01/2018 - 10/2004
13	Hemorrhage 01/2021 - 09/2009
11	Myocardial Infarction 03/2024 - 07/2002
10	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 05/2007
8	Inflammation (Inflammations) 04/2024 - 10/2010
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2012
7	Atherosclerosis 01/2024 - 10/2010
5	Atrial Fibrillation 11/2023 - 09/2010
5	Thrombosis (Thrombus) 01/2021 - 11/2010
5	Vascular Diseases (Vascular Disease) 09/2013 - 01/2008
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2024 - 08/2012
4	Lacunar Stroke 01/2023 - 01/2016
4	Leukoaraiosis 01/2023 - 09/2012
4	Cerebral Hemorrhage 10/2021 - 10/2006
4	Embolic Stroke 03/2019 - 12/2012
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018 - 09/2015
3	Cognitive Dysfunction 01/2023 - 11/2014
3	Coronary Disease (Coronary Heart Disease) 01/2023 - 10/2004
3	Dementia (Dementias) 06/2020 - 11/2009
3	Diabetes Mellitus 01/2020 - 10/2014
3	Peripheral Arterial Disease 01/2019 - 09/2010
3	Neoplasm Metastasis (Metastasis) 07/2014 - 04/2012
3	Adenoma (Adenomas) 01/2013 - 05/2007
2	CADASIL 11/2023 - 01/2023
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 09/2013
2	Leukoencephalopathies 01/2020 - 07/2015
2	Cerebral Small Vessel Diseases 10/2018 - 03/2015
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017 - 05/2014
2	Migraine Disorders (Migraine) 10/2015 - 01/2013
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 07/2014 - 02/2012
2	Acute Coronary Syndrome 10/2013 - 05/2010
2	Venous Thromboembolism 09/2013 - 08/2012
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 05/2012 - 01/2011
2	Infarction (Infarctions) 12/2009 - 05/2008
1	Hyperlipidemias (Hyperlipidemia) 11/2023
1	Dehydration (Water Stress) 11/2023
1	Frailty 05/2023

Drug/Important Bio-Agent (IBA)

26	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 10/2004
15	danaparoid (Orgaran)FDA Link 11/2023 - 03/2011
15	Antihypertensive Agents (Antihypertensives)IBA 11/2023 - 03/2010
10	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2013
6	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 11/2011
5	omega-Chloroacetophenone (Mace)IBA 04/2024 - 04/2016
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024 - 10/2013
5	terutrobanIBA 03/2019 - 11/2011
5	LipidsIBA 01/2019 - 01/2005
4	Fibrinogen (Factor I)FDA Link 04/2024 - 10/2004
4	C-Reactive ProteinIBA 01/2024 - 01/2005
4	Amlodipine (Norvasc)FDA LinkGeneric 11/2023 - 05/2010
4	AnticoagulantsIBA 01/2021 - 09/2009
3	Retinaldehyde (Retinal)IBA 03/2024 - 09/2006
3	Interleukin-6 (Interleukin 6)IBA 01/2024 - 10/2014
3	Atenolol (Tenormin)FDA LinkGeneric 11/2023 - 05/2010
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 03/2015
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2020 - 05/2010
3	Angiotensin Receptor AntagonistsIBA 01/2020 - 09/2010
3	CholesterolIBA 01/2019 - 04/2005
3	ORALIT (ORS)IBA 01/2017 - 01/2004
3	CreatinineIBA 12/2015 - 11/2014
2	Losartan (Cozaar)FDA LinkGeneric 11/2023 - 12/2015
2	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 12/2022 - 09/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
2	Mitochondrial DNA (mtDNA)IBA 01/2022 - 05/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	A-factor (Streptomyces)IBA 01/2022 - 10/2004
2	cyclo(Arg-Pro) (CI 4)IBA 10/2021 - 07/2002
2	Proton Pump InhibitorsIBA 01/2021 - 01/2016
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021 - 01/2017
2	Calcium Channels (Calcium Channel)IBA 01/2020 - 01/2019
2	Valsartan (Vals)FDA Link 01/2020 - 01/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 01/2019
2	Nitroglycerin (Dynamite)FDA LinkGeneric 11/2019 - 01/2019
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 03/2016
2	Clopidogrel (Plavix)FDA Link 01/2018 - 01/2016
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2018 - 02/2012
2	Dipyridamole (Persantine)FDA LinkGeneric 01/2018 - 07/2016
2	Lipoproteins (Lipoprotein)IBA 01/2017 - 01/2005
2	AlbuminsIBA 12/2015 - 12/2014
2	CollagenIBA 03/2015 - 03/2010
2	DiureticsIBA 10/2014 - 05/2010
2	Lipoprotein(a)IBA 08/2012 - 01/2005
1	amlodipine-losartan drug combinationIBA 11/2023

Therapy/Procedure

35	Secondary Prevention 04/2024 - 01/2003
29	Therapeutics 05/2024 - 01/2005
21	Endarterectomy (Thromboendarterectomy) 01/2021 - 01/2004
18	Carotid Endarterectomy 01/2017 - 07/2003
8	Length of Stay 05/2023 - 10/2006
3	Institutionalization (Institutionalized Persons) 06/2020 - 10/2013
3	Stents 08/2019 - 07/2009
2	Thrombectomy 01/2024 - 06/2020
2	Contraindications 11/2015 - 06/2010
2	Chemoprevention 01/2013 - 02/2012
2	Emergency Treatment 12/2007 - 03/2005
1	Vascular Surgical Procedures 03/2024